相关实验视频
Updated: Jul 10, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.4K
先天性肌肉病的简要历史 - 肌肉病理学的视角
Hans H Goebel1, Werner Stenzel2
1Institute of Neuropathology, Charite Universitätsmedizin, Berlin, Germany; Department of Neuropathology, Universitätsmedizin, Mainz, Germany.
Neuromuscular disorders : NMD
|November 18, 2023
概括
先天性肌肉病,一组遗传性肌肉疾病,越来越多地由遗传突变而不是仅仅由不同的病理病变来定义. 这种转变影响了它们的分类和命名法.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 病理学 病理学 病理学
背景情况:
- 先天性肌肉病是一种遗传性神经肌肉疾病,其特点是早期发病和缓慢进展.
- 从历史上看,诊断依赖于肌肉活检和特定的神经病理病变.
- 诊断技术的发展扩大了对这些疾病的理解和分类.
研究的目的:
- 追踪先天性肌肉病诊断和分类的历史演变.
- 突出技术进步对识别和定义先天性肌肉病变的影响.
- 讨论分子遗传学对当前和未来命名体系的影响.
主要方法:
- 历史诊断技术的审查,包括组织病理学,电子显微镜和酶组织化学.
- 在肌肉活检中用于蛋白质分析的免疫组织化学的整合.
- 分子遗传学的应用,用于识别与先天性肌肉病相关的基因突变.
主要成果:
- 已确定的先天性肌肉病变的数量显著增长,许多现在是由特定的基因突变定义的.
- 分子遗传学导致了新的先天性肌肉病变的描述,有时没有独特的病理特征.
- 拟议的命名体系将基因突变与已确定的或新确定的先天性肌肉病变结合起来.
结论:
- 先天性肌肉病的分类正在从基于形态学的转变为基于遗传学的定义.
- 分子数据的整合需要修订命名体系,可能包括基因名称.
- 需要进一步的研究,以追溯对历史描述的先天性肌肉病的分子特征进行研究.
相关概念视频
Disorders of the Skeletal Muscle
966
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
966
Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Formation of Muscle Fibers from Myoblasts
4.9K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.9K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Sex-linked Disorders
102.3K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
102.3K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K

